Why the study?
Is pulmonary vein antrum isolation effective and safe for the treatment of drug-refractory atrial fibrillation in adults with congenital heart disease compared to those with noncongenital structural heart disease?
Population
391 adults undergoing pulmonary vein antrum isolation for drug-refractory atrial fibrillation at a single…
Comparison
Pulmonary vein antrum isolation for… vs Pulmonary vein antrum isolation in a…
Design
Cohort
Follow-up
Up to 4 years
Authors
Loading...
PVI may be considered for AF in CHD; Level 3 evidence leaves open randomized confirmation of outcomes.
Is pulmonary vein antrum isolation effective and safe for the treatment of drug-refractory atrial fibrillation in adults with congenital heart disease compared to those with noncongenital structural heart disease?
Pulmonary vein antrum isolation provides similar long-term efficacy for drug-refractory atrial fibrillation in adults with congenital heart disease compared to those with noncongenital structural heart disease, though with a higher risk of vascular access complications.
Philip et al. (2012) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: